This company listing is no longer active
Guangdong Taiantang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Guangdong Taiantang Pharmaceutical has a total shareholder equity of CN¥340.5M and total debt of CN¥780.9M, which brings its debt-to-equity ratio to 229.3%. Its total assets and total liabilities are CN¥3.3B and CN¥2.9B respectively.
Key information
229.3%
Debt to equity ratio
CN¥780.92m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥93.59m |
| Equity | CN¥340.53m |
| Total liabilities | CN¥2.94b |
| Total assets | CN¥3.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002433's short term assets (CN¥1.1B) do not cover its short term liabilities (CN¥2.3B).
Long Term Liabilities: 002433's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥608.5M).
Debt to Equity History and Analysis
Debt Level: 002433's net debt to equity ratio (201.8%) is considered high.
Reducing Debt: 002433's debt to equity ratio has increased from 43.3% to 229.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002433 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 002433 has sufficient cash runway for 2.1 years if free cash flow continues to grow at historical rates of 26.8% each year.